(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 10323.91 | 8897.79 | 16.03 | 29173.25 | 23255.89 | 25.44 | 32384.37 | 31349.82 | 3.30 |
| Other Income | -9.28 | 47.85 | -119.39 | 73.71 | 164.24 | -55.12 | 175.10 | 137.23 | 27.60 |
| PBIDT | 2376.91 | 1968.24 | 20.76 | 6283.14 | 4519.12 | 39.03 | 6621.59 | 8750.96 | -24.33 |
| Interest | 117.56 | 29.56 | 297.70 | 245.56 | 123.52 | 98.80 | 163.52 | 237.74 | -31.22 |
| PBDT | 2259.35 | 1938.68 | 16.54 | 6037.58 | 4395.60 | 37.36 | 6458.07 | 8513.22 | -24.14 |
| Depreciation | 383.21 | 311.27 | 23.11 | 1077.88 | 944.79 | 14.09 | 1261.61 | 1184.51 | 6.51 |
| PBT | 1876.14 | 1627.41 | 15.28 | 4959.70 | 3450.81 | 43.73 | 5196.46 | 7328.71 | -29.09 |
| TAX | 478.15 | 414.12 | 15.46 | 1224.74 | 878.11 | 39.47 | 1331.31 | 1800.87 | -26.07 |
| Deferred Tax | -23.77 | -7.17 | 231.52 | -62.85 | -15.20 | 313.49 | -3.76 | -169.74 | -97.78 |
| PAT | 1397.99 | 1213.29 | 15.22 | 3734.96 | 2572.70 | 45.18 | 3865.15 | 5527.84 | -30.08 |
| Equity | 242.04 | 248.01 | -2.41 | 248.29 | 248.01 | 0.11 | 248.01 | 247.68 | 0.13 |
| PBIDTM(%) | 23.02 | 22.12 | 4.08 | 21.54 | 19.43 | 10.83 | 20.45 | 27.91 | -26.75 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1938.85 |
| Dr. Reddys Labs. | 1269.80 |
| Cipla | 1441.70 |
| Zydus Lifesciences | 1159.85 |
| Lupin | 2502.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: